Gabalex-AT Tablet SR is a sustained-release formulation combining Gabapentin 300mg and Amitriptyline 10mg, designed to provide effective management of neuropathic pain and certain types of chronic pain conditions. Gabapentin, an anticonvulsant, works by modulating calcium channels in the nervous system to reduce nerve excitability and alleviate pain signals, while Amitriptyline, a tricyclic antidepressant, enhances pain relief through its action on neurotransmitters such as serotonin and norepinephrine, also contributing to improved mood and sleep quality. The sustained-release mechanism ensures a gradual release of active ingredients, promoting prolonged therapeutic effects and improved patient compliance by reducing dosing frequency. Gabalex-AT is commonly prescribed for conditions like diabetic neuropathy, postherpetic neuralgia, and fibromyalgia, where conventional painkillers may be insufficient. Patients should use this medication under medical supervision, as it may cause side effects including dizziness, drowsiness, dry mouth, and gastrointestinal discomfort. It is important to avoid abrupt discontinuation to prevent withdrawal symptoms. Gabalex-AT should be used cautiously in individuals with a history of cardiac issues, glaucoma, or kidney impairment. Overall, Gabalex-AT Tablet SR offers a balanced approach to managing complex neuropathic pain by combining two complementary agents in a convenient sustained-release form.